Our research and development enterprise spans small molecule and biologic therapeutics, medical devices and gene therapies. 

Over 1,000 scientists comprise our global R&D team. 

Our esteemed scientists are the recipients of numerous awards and are recognized leaders in the industry. 

Currently, we focus our research efforts on cardiovascular disease, metabolic disease, oncology, and bone diseases. 

We have more than 100 products in the pipeline and below are some examples of on-going programs.